CCL2 and metabolic dysfunction-associated steatotic liver disease: In our study, ANGPTL8 does not facilitate the release of classical chemokines, such as MCP1 (CCL2), MIP-α (CCL3), and MIP-β (CCL4), which have been previously implicated in NAFLD/NASH42.